Verona Pharma American Depositary Share Return On Tangible Equity 2017-2024 | VRNA

Verona Pharma American Depositary Share return on tangible equity for the quarter ending December 31, 2024 was -95.87.

  • Verona Pharma American Depositary Share average return on tangible equity for 2023 was -22.35, a 47.95% increase from 2022.
  • Verona Pharma American Depositary Share average return on tangible equity for 2022 was -42.94, a 2.98% decline from 2021.
  • Verona Pharma American Depositary Share average return on tangible equity for 2021 was -44.26, a 57.71% decline from 2020.

Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.

Verona Pharma American Depositary Share Return On Tangible Equity 2017-2024 | VRNA

  • Verona Pharma American Depositary Share average return on tangible equity for 2023 was -22.35, a 47.95% increase from 2022.
  • Verona Pharma American Depositary Share average return on tangible equity for 2022 was -42.94, a 2.98% decline from 2021.
  • Verona Pharma American Depositary Share average return on tangible equity for 2021 was -44.26, a 57.71% decline from 2020.

Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.